Some treatment guidelines suggest that active surveillance may be an option for certain men with intermediate-risk prostate cancer, although the practice is controversial.
When men discuss screening for prostate cancer with their physicians, some ask: Do I really need the digital rectal exam (DRE)? This physical evaluation allows doctors to check for growths and other abnormalities on the prostate that could signal the presence of cancer, but it also causes anxiety in many men.
Men diagnosed with prostate cancer are faced with an array of prostate treatment options. Proton beam therapy—a form of external beam radiation therapy—is the latest choice now available in the United States. But it’s a controversial option as well, with some critics suggesting that its popularity may be driven by advertising rather than by sound scientific evidence of benefit over other therapies.
Perhaps you've had hormone therapy for prostate cancer, but your prostate-specific antigen (PSA) level is rapidly rising. What are your options? If you have a prostate condition and find yourself in a situation where your current treatment choices are unsatisfactory, you may want to enroll in a clinical trial.
If your doctor suspects you have prostate cancer, undergoing a magnetic resonance imaging (MRI) scan immediately after an initial screening might spare you the medical risks of a prostate biopsy and improve your chances of an accurate diagnosis.
When the influential U.S. Preventive Services Task Force recommended against routine screening for prostate cancer in 2012, many men were surprised, confused, or even angry. Some men followed the advice and stopped getting screened or didn't start, while others ignored it. Now the Task Force has changed its collective mind.